BACKGROUND AND OBJECTIVE: The 30-day expected mortality rate is frequently used as
a metric to determine which patients benefit from palliative radiation treatment (RT). We …

Purpose To review available and emerging evidence of radiotherapy for symptom
management and disease control in metastatic bladder cancer. Methods A literature search …

Objectives: Differentiate gross hematuria and microscopic hematuria. Implement evidence-
based protocols for the evaluation of patients with gross and microscopic hematuria. Select …

This study assessed the efficacy of palliative radiotherapy for gross hematuria caused by
advanced cancer. Patients who received palliative radiotherapy to control gross hematuria …

Bladder cancer is one of the most common malignant tumors of the urinary system globally.
It is also one of the most expensive cancers to manage, due to the need for extensive …

Abstract Background/Purpose The optimal dose fractionation for palliative radiotherapy (RT)
in patients with symptomatic advanced bladder cancer is unclear. This study aimed to …

BACKGROUND AND OBJECTIVE: In locally advanced cancer, bleeding is a common
clinical presentation and radiotherapy (RT) provides a noninvasive, well-tolerated, cost …

Background Significant bleeding of tumor sites is a dreaded complication in oncological
diseases and often results in clinical emergencies. Besides basic local and interventional …

Bladder cancer (BC) accounts for roughly 3% of all cancer diagnoses in developed
countries. The prognosis could be improved significantly if the cancer is detected and …

Bladder cancer is the 6th most common cancer worldwide and contributes significant excess
mortality and morbidity. It often presents at a late stage when it is incurable, and the …